clinical trial · NCT07677254
A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer
Prostatic Neoplasms, Castration-Resistant
brief summary
The aim of this study is to assess treatment patterns, clinical outcomes, and patient characteristics among adults with metastatic castration-resistant prostate cancer (mCRPC) in the United States (US) real-world clinical practice. This study will be conducted using data extracted from the PRECISION (PRostatE Cancer dISease observatION) data platform.
started
Jun 30, 2026
primary completion
Nov 30, 2026
completion
Nov 30, 2026
last updated
Jun 30, 2026
official title
Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Contemporary Patients With Metastatic Castration-Resistant Prostate Cancer in the PRECISION Data Platform
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol